SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 179 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $402,234 | +3.1% | 128,100 | +36.1% | 0.01% | -16.7% |
| Q2 2022 | $390,000 | -28.8% | 94,100 | 0.0% | 0.01% | -14.3% |
| Q1 2022 | $548,000 | -56.3% | 94,100 | -43.5% | 0.01% | -50.0% |
| Q4 2021 | $1,253,000 | -4.2% | 166,476 | +14.7% | 0.01% | -6.7% |
| Q3 2021 | $1,308,000 | -2.9% | 145,100 | +28.7% | 0.02% | -16.7% |
| Q2 2021 | $1,347,000 | -56.8% | 112,765 | -54.8% | 0.02% | -73.5% |
| Q1 2021 | $3,120,000 | +78.6% | 249,206 | +122.5% | 0.07% | +74.4% |
| Q4 2020 | $1,747,000 | +144.0% | 112,000 | +40.0% | 0.04% | +62.5% |
| Q2 2020 | $716,000 | +6.9% | 80,000 | -23.8% | 0.02% | -35.1% |
| Q1 2020 | $670,000 | +23.4% | 105,000 | +61.5% | 0.04% | +105.6% |
| Q4 2019 | $543,000 | +71.3% | 65,000 | +85.7% | 0.02% | +12.5% |
| Q3 2019 | $317,000 | -94.7% | 35,000 | -93.7% | 0.02% | -94.7% |
| Q2 2019 | $6,002,000 | +1697.0% | 557,200 | +1492.0% | 0.30% | +1583.3% |
| Q1 2019 | $334,000 | -61.9% | 35,000 | -43.2% | 0.02% | -73.5% |
| Q2 2018 | $876,000 | – | 61,667 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FIC CAPITAL INC | 875,284 | $2,670,000 | 1.34% |
| NEXTHERA CAPITAL LP | 503,000 | $1,534,000 | 0.90% |
| Opaleye Management Inc. | 400,000 | $1,220,000 | 0.72% |
| WASATCH ADVISORS LP | 7,256,260 | $22,132,000 | 0.33% |
| Cormorant Asset Management, LP | 650,000 | $1,983,000 | 0.27% |
| Sicart Associates LLC | 101,950 | $311,000 | 0.22% |
| Baker Brothers Advisors | 4,055,876 | $12,370,000 | 0.12% |
| Leisure Capital Management | 43,008 | $131,000 | 0.12% |
| Piermont Capital Management Inc. | 165,569 | $505,000 | 0.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 837,963 | $2,556,000 | 0.10% |